Birtamimab (NEOD001) is an investigational моноклональный антитело that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis.
Birtamimab (NEOD001) is an investigational monoclonal antibody that specifically and selectively target and clear the amyloid. Birtamimab can be used for the research of light chain amyloidosis.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.